Prosecution Insights
Last updated: April 19, 2026
Application No. 17/940,868

DELIVERY SYSTEM CONFIGURATIONS

Non-Final OA §102
Filed
Sep 08, 2022
Examiner
MANNAN, MIKAIL A
Art Unit
3774
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Edwards Lifesciences Corporation
OA Round
1 (Non-Final)
69%
Grant Probability
Favorable
1-2
OA Rounds
3y 6m
To Grant
92%
With Interview

Examiner Intelligence

Grants 69% — above average
69%
Career Allow Rate
208 granted / 302 resolved
-1.1% vs TC avg
Strong +24% interview lift
Without
With
+23.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
63 currently pending
Career history
365
Total Applications
across all art units

Statute-Specific Performance

§101
1.1%
-38.9% vs TC avg
§103
44.8%
+4.8% vs TC avg
§102
26.2%
-13.8% vs TC avg
§112
21.4%
-18.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 302 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of the invention of Group I and Species A in the reply filed on 11/6/25 is acknowledged. Response to Amendment This action is entered in response to Applicant's amendment and reply of 11/6/25. The claims 13, 17-34 are pending. Claims 1-12, 14-16 have been cancelled. Claim Interpretation The following is a quotation of 35 U.S.C. 112(f): (f) Element in Claim for a Combination. – An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The following is a quotation of pre-AIA 35 U.S.C. 112, sixth paragraph: An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The claims in this application are given their broadest reasonable interpretation using the plain meaning of the claim language in light of the specification as it would be understood by one of ordinary skill in the art. The broadest reasonable interpretation of a claim element (also commonly referred to as a claim limitation) is limited by the description in the specification when 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is invoked. As explained in MPEP § 2181, subsection I, claim limitations that meet the following three-prong test will be interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph: (A) the claim limitation uses the term “means” or “step” or a term used as a substitute for “means” that is a generic placeholder (also called a nonce term or a non-structural term having no specific structural meaning) for performing the claimed function; (B) the term “means” or “step” or the generic placeholder is modified by functional language, typically, but not always linked by the transition word “for” (e.g., “means for”) or another linking word or phrase, such as “configured to” or “so that”; and (C) the term “means” or “step” or the generic placeholder is not modified by sufficient structure, material, or acts for performing the claimed function. Use of the word “means” (or “step”) in a claim with functional language creates a rebuttable presumption that the claim limitation is to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites sufficient structure, material, or acts to entirely perform the recited function. Absence of the word “means” (or “step”) in a claim creates a rebuttable presumption that the claim limitation is not to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is not interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites function without reciting sufficient structure, material or acts to entirely perform the recited function. Claim limitations in this application that use the word “means” (or “step”) are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. Conversely, claim limitations in this application that do not use the word “means” (or “step”) are not being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. This application includes one or more claim limitations that do not use the word “means,” but are nonetheless being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, because the claim limitation(s) uses a generic placeholder that is coupled with functional language without reciting sufficient structure to perform the recited function and the generic placeholder is not preceded by a structural modifier. Such claim limitation(s) is/are: “retention member” in claim 26. For examination purposes the “retention member” is interpreted as a “ring and can include a plurality of slots configured to engage with struts of the prosthesis 70” as described in paragraph [0155] of the instant specification and equivalents thereof. Because this/these claim limitation(s) is/are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, it/they is/are being interpreted to cover the corresponding structure described in the specification as performing the claimed function, and equivalents thereof. If applicant does not intend to have this/these limitation(s) interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, applicant may: (1) amend the claim limitation(s) to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph (e.g., by reciting sufficient structure to perform the claimed function); or (2) present a sufficient showing that the claim limitation(s) recite(s) sufficient structure to perform the claimed function so as to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale or otherwise available to the public before the effective filing date of the claimed invention. Claims 13, 17-34 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Crowley (US2017/0216029). Regarding claim 13, Crowley discloses a delivery system for a replacement heart valve ([0059]), the delivery system comprising: a shaft (14) having a proximal end and a distal end; a manifold (50) on a distal end of the shaft, wherein the manifold comprises a plurality of radially extending apertures (54, 56); at least one attachment tether (90) configured to releasably connect to the replacement heart valve ([0079]), wherein looped portions (94) of the at least one attachment tether extend through the radially extending apertures of the manifold; and a release tether (42) configured to extend through the looped ends of the at least one attachment tether ([0077]); wherein when the release tether is withdrawn from the looped portions ([0080]), the replacement heart valve is released from the at least one attachment tether ([0081]). Regarding claim 17, Crowley discloses the delivery system of Claim 13, wherein the at least one attachment tether comprises one and only one attachment tether (attachment tether can be single filament 90, [0079]). Regarding claim 18, Crowley discloses the delivery system of Claim 13, wherein the at least one attachment tether comprises a plurality of attachment tethers (attachment tether can be a plurality of filaments 90, [0079], see Fig. 4). Regarding claim 19, Crowley discloses a delivery system for a replacement heart valve ([0059]), the delivery system comprising: a shaft (14) having a proximal end, a distal end, and a lumen (see Fig. 1, [0060]); a handle (18) coupled to the proximal end of the shaft; a manifold assembly (50) configured to be positioned on or within the shaft (see Fig. 6), the manifold assembly comprising at least one attachment tether (90) configured to releasably connect to the replacement heart valve ([0079]), the at least one attachment tether comprising looped ends (94); and a release tether (42) having a free end (end of the post 42) configured to extend through the looped ends of the at least one attachment tether ([0077]); wherein the release tether is configured to withdraw from the looped ends ([0080]) such that the replacement heart valve is released from the at least one attachment tether ([0081]). Regarding claim 20, Crowley discloses the delivery system of Claim 19, wherein the at least one attachment tether (90) is configured to extend through at least one eyelet (eyelet is interpreted as the opening in the crown portion 98) of a replacement heart valve prosthesis (see Fig. 6). Regarding claim 21, Crowley discloses the delivery system of Claim 19, wherein the plurality of attachment tethers comprises 9 attachment tethers (three filaments 90 may be coupled to each cleat post 42, [0078]; where there may be three cleat posts 42, [0074]). Regarding claim 22, Crowley discloses the delivery system of Claim 19, wherein the replacement heart valve is configured to transition from a collapsed configuration to a fully expanded configuration, wherein the at least one attachment tether is configured to releasably connect to the replacement heart valve such that the replacement heart valve can transition to the fully expanded configuration while remaining connected to the delivery system ([0067], [0072]). Regarding claim 23, Crowley discloses the delivery system of Claim 19, wherein the release tether comprises a plurality of release tethers (include a plurality of posts 42, [0074], see Fig. 4). Regarding claim 24, Crowley discloses the delivery system of Claim 23, wherein individual release tethers are configured to extend through multiple looped ends ([0074], see Fig. 4). Regarding claim 25, Crowley discloses the delivery system of Claim 19, wherein the release tether is configured to be pulled to withdraw the release tether and enable the looped ends to detach the looped ends from the replacement heart valve ([0081]). Regarding claim 26, Crowley discloses a delivery system for a replacement heart valve ([0059]), the delivery system comprising: a shaft (14) having a proximal end and a distal end (see Fig. 1, [0060]); a retention member (50, where 50 is interpreted under 112(f) as a “retention member” by being a ring, which is shaped like a disk and for holding the valve as shown in Fig. 6) on or within a distal end portion of the shaft (see Fig. 6); a plurality of attachment tethers (90, where 90 can be a plurality of filaments, [0079], see Fig. 4) at least partially disposed within the shaft ([0076], see Fig. 6) and configured to releasably couple to a replacement heart valve ([0079]), the plurality of attachment tethers comprising looped ends (94); and one or more release tethers (42) configured to extend through at least some of the looped ends of the plurality of attachment tethers ([0077]), the one or more release tethers comprising a free end (free end of the post 42); wherein the delivery system is configured to transition from a first configuration (first configuration is interpreted as the “deployed” configuration when the valve is expanded but the filaments 90 are not pulled from the post 42, [0072]) to a second configuration (second configuration is interpreted as the “release” configuration when the filament 90 is pulled from the post 42 to release the valve, [0072]); wherein the delivery system is in the first configuration when the one or more release tethers are extended through at least some of the looped ends of the plurality of attachment tethers ([0077]); wherein the delivery system is in the second configuration when the one or more release tethers are withdrawn from at least some of the looped ends of the plurality of attachment tethers ([0080]); wherein the replacement heart valve is inhibited from decoupling from the plurality of attachment tethers when the delivery system is in the first configuration ([0067], [0072]), and the replacement heart valve is configured to be released from the plurality of attachment tethers after the delivery system is in the second configuration ([0067], [0072]). Regarding claim 27, Crowley discloses he delivery system of Claim 26, wherein the plurality of attachment tethers (90) is configured to extend through eyelets (eyelet is interpreted as the opening in the crown portion 98) of a replacement heart valve prosthesis (see Fig. 6). Regarding claim 28, Crowley discloses the delivery system of Claim 26, wherein the replacement heart valve is configured to transition from a collapsed configuration to a fully expanded configuration, wherein the plurality of attachment tethers is configured to releasable couple to the replacement heart valve such that the replacement heart valve can transition to the fully expanded configuration while remaining coupled to the delivery system ([0067], [0072]). Regarding claim 29, Crowley discloses the delivery system of Claim 26, wherein the one or more release tethers comprises a plurality of release tethers (include a plurality of posts 42, [0074], see Fig. 4). Regarding claim 30, Crowley discloses the delivery system of Claim 29, wherein individual release tethers are configured to extend through multiple looped ends ([0074], see Fig. 4). Regarding claim 31, Crowley discloses delivery system of Claim 26, wherein the replacement heart valve is configured to cinch the plurality of attachment tethers (the posts 42 are cinched by the filaments 90 that are connected to the heart valve, therefore the heart valve at least indirectly cinches the posts 42, [0077]). Regarding claim 32, Crowley discloses delivery system of Claim 26, wherein the release tether is configured to be pulled to withdraw the release tether and enable the looped ends to detach the looped ends from the replacement heart valve (see Figs. 7 and 8). Regarding claim 33, Crowley discloses the delivery system of Claim 26, wherein a portion of the individual attachment tethers are attached to the shaft (at least indirectly attached to the shaft 14 by the coupler 50, [0074]). Regarding claim 34, Crowley discloses delivery system of Claim 26, wherein the plurality of attachment tethers are attached to the retention member (disc 40 is attached to the coupler 50 by extending within it, [0074]). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to MIKAIL A MANNAN whose telephone number is (571)270-1879. The examiner can normally be reached M-F 10-6. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Melanie Tyson can be reached on (571)272-9062. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /M.A.M/Examiner, Art Unit 3774 /THOMAS C BARRETT/SPE, Art Unit 3799
Read full office action

Prosecution Timeline

Sep 08, 2022
Application Filed
Jan 16, 2026
Non-Final Rejection — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599386
DEVICES, SYSTEMS, AND METHODS FOR TREATING THE LEFT ATRIAL APPENDAGE
2y 5m to grant Granted Apr 14, 2026
Patent 12575849
ULTRASONIC SURGICAL INSTRUMENTS HAVING OFFSET BLADES
2y 5m to grant Granted Mar 17, 2026
Patent 12575921
STENT AND SLEEVE DEPLOYMENT
2y 5m to grant Granted Mar 17, 2026
Patent 12569338
DILATING INTRODUCER DEVICES AND METHODS FOR VASCULAR ACCESS
2y 5m to grant Granted Mar 10, 2026
Patent 12527576
REINFORCEMENT DEVICE FOR INTRASACCULAR TREATMENT OF AN ANEURYSM
2y 5m to grant Granted Jan 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
69%
Grant Probability
92%
With Interview (+23.5%)
3y 6m
Median Time to Grant
Low
PTA Risk
Based on 302 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month